Active Biotech ABOSTO:ACTI +0.44%19 9-Day RSI is 39.69 as of Jul. 06, 2026. GuruFocus rates OSTO:ACTI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 1,418 Biotechnology companies, Active Biotech AB ranks better than 82.16% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Active Biotech AB's 9-Day RSI or its related term are showing as below:
OSTO:ACTI's 9-Day RSI is ranked better than 82.16% of 1418
companies
in the Biotechnology industry
Industry Median: 53.705
vs OSTO:ACTI: 39.69
Active Biotech AB (OSTO:ACTI) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Active Biotech AB 9-Day RSI Related Terms
OSTO:ACTI vs VRTX, REGN, ALNY: 9-Day RSI Comparison
For the Biotechnology subindustry, Active Biotech AB's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Active Biotech AB 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Active Biotech AB's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Active Biotech AB's 9-Day RSI falls into.
Active Biotech AB (OSTO:ACTI) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Active Biotech AB (OSTO:ACTI) has a 9-Day RSI of 39.69 as of Jul. 06, 2026. According to the industry distribution chart, Active Biotech AB ranks #253 out of 1418 companies in the Biotechnology industry, placing it in the top 17.8%.
Is Active Biotech AB's 9-Day RSI too high?
Active Biotech AB's current 9-Day RSI is 39.69. The Biotechnology industry median 9-Day RSI is 53.71. Active Biotech AB's value of 39.69 is 26.1% below this industry median. Based on the distribution chart, Active Biotech AB ranks #253 out of 1418 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Active Biotech AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's 9-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Active Biotech AB ranks #253 out of 1418 companies for 9-Day RSI. This places Active Biotech AB in the top 18% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 53.71. Active Biotech AB's value of 39.69 is 26.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 53.71, based on 1,418 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Active Biotech AB's current 9-Day RSI of 39.69 is 26.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 53.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Active Biotech AB's current 9-Day RSI is 39.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (OSTO:ACTI) has a current 9-Day RSI of 39.69. The current 9-Day RSI is 39.69 and 26.1% below the Biotechnology industry median of 53.71. Active Biotech AB's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Active Biotech AB (OSTO:ACTI), the current 9-Day RSI is 39.69 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
19GF Score
Get the complete analysis for OSTO:ACTI
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ACTI has been successfully added to your 